Objective To assess the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) patients with
refractory disease and/or with unacceptable side effects due to corticosteroids. Methods A …

Objective. The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory
uveitis due to Behçet’s disease (BD). Methods. We performed a multicentre study of 124 …

Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA).
Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in …

Purpose Cystoid macular edema (CME) is a leading cause of blindness. This study assessed
the efficacy and safety of tocilizumab (TCZ) in refractory CME. Design Retrospective case …

Objective. Non-infectious aortitis is often refractory to standard immunosuppressive therapy.
Since IL-6 has been implicated in the pathogenesis of aortitis, we assessed the efficacy of …

Objective To compare the efficacy of infliximab ( IFX ) versus adalimumab ( ADA ) as a first‐line
biologic drug over 1 year of treatment in a large series of patients with refractory uveitis …

Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease
(GD). Our aim was to assess the efficacy and safety of Tocilizumab (TCZ) in GO refractory …

Purpose To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy
optimization in a large series of patients with uveitis due to Behçet disease (BD) who achieved …

Objectives: We aimed to evaluate the drug retention rate and safety of secukinumab (SEC)
in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) in a real clinical …

Objective: To characterise the circulating cytokine profile and the cellular source of circulating
cytokines in polymyalgia rheumatica (PMR). Methods: The study included 34 patients with …